Reinhard Vogt Overview
- Firm
- Avant Bio
- Primary Position
-
Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
3
- Med. Deal Size
-
- Med. Valuation
-
Reinhard Vogt General Information
Biography
Mr. Reinhard Vogt serves as a Partner at Avant Bio. He also serves as a Venture Partner at Dynamk Capital. He serves as Chairman at Bionter. He serves as a Board Member at Vectron Biosolutions and Lucid Scientific. He brings a wealth of industry knowledge, technology deal-side expertise, and numerous technology licenses, acquisitions, and integrations derived from over 30 years at one of the industry's largest players. For investors and portfolio companies, this means a winning combination of commercial and operational support owed to his experience with more than a dozen high-profile, accretive deals throughout his time at Sartorius Stedim Biotech S.A (Sartorius), a leading international partner to biotechnology and pharmaceutical companies, providing critical solutions for research, development, and manufacturing. Beginning in the 1990s and up to his last role as Executive VP and Member of the Board of Sartorius, he was instrumental in building and transforming Sartorius' filtration business from €30 million in revenue to what is today the Sartorius Bioprocess Business of around €2.8 billion in revenue. He led the transformation of Sartorius' strategy to become the leader in single-use bioprocessing technologies and revolutionized how biologics are manufactured. His track record includes technology licenses and acquisitions ranging from the Stedim SA and B.Braun Biotech transactions to more recent deals, including TAP Biosystems, Cellca, BioOutsource, and Umetrics. He served as Director of 15 companies and Sartorius affiliates in his career and has also established operations in Australia, China, India, Korea, and Turkey.
Contact Information
Address
- Germany
Reinhard Vogt Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Avant Bio | Investor | Partner | New York, NY | Growth/Expansion | |
Dynamk Capital | Investor | Venture Partner | New York, NY | Venture Capital |
Reinhard Vogt Board Seats (3)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Bionter | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Riehen, Switzerland | |
Lucid Scientific | Other Pharmaceuticals and Biotechnology | Privately Held (backing) | Venture Capital-Backed | Atlanta, GA | |
Vectron Biosolutions | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Trondheim, Norway |
Reinhard Vogt Lead Partner on Deals (6)
Reinhard Vogt has been the lead partner on 6 deals. Their latest deal was with Lucid Scientific, a other pharmaceuticals and biotechnology company. The deal was made for on 05-Sep-2023.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Lucid Scientific | 05-Sep-2023 | Later Stage VC (Series A) | Completed | Other Pharmaceuticals and Biotechnology | Atlanta, GA | |
Bionter | 27-Apr-2022 | Completed | Biotechnology | Riehen, Switzerland | ||
Vectron Biosolutions | 17-Jun-2021 | Completed | Biotechnology | Trondheim, Norway | ||
Lucid Scientific | 01-Oct-2020 | Completed | Other Pharmaceuticals and Biotechnology | Atlanta, GA | ||
kSep Systems | 29-Jul-2016 | Merger/Acquisition | Completed | Other Devices and Supplies | Morrisville, NC | |
Sartorius Stedim Biotech | 27-Jul-2007 | Merger/Acquisition | Completed | Other Pharmaceuticals and Biotechnology | Aubagne, France |
Reinhard Vogt Network (51)
Board Members (30)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Anne-Marie Graffin | Sartorius Stedim Biotech | Self | Aubagne, France | |
Bernard Lemaitre | Sartorius Stedim Biotech | Sartorius Stedim Biotech | Aubagne, France | |
Bionter | Self | Riehen, Switzerland | ||
Bionter | Self | Riehen, Switzerland | ||
Sartorius | Self | Goettingen, Germany |
Portfolio Executives (17)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Samuel Inman Ph.D | Lucid Scientific | Co-Founder, Chief Executive Officer, President & Board Member | 05-Sep-2023 | Atlanta, GA |
Eric Bleke | Lucid Scientific | Chief Operating Officer | 05-Sep-2023 | Atlanta, GA |
Lucid Scientific | Controller | 05-Sep-2023 | Atlanta, GA | |
Lucid Scientific | Co-Founder | 05-Sep-2023 | Atlanta, GA | |
Lucid Scientific | Co-Founder & Board Member | 05-Sep-2023 | Atlanta, GA |
Fund Team Members (4)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Jessica Davis | Avant Bio | Avant Bio Fund II | New York, NY |
Sebastien Latapie | Avant Bio | Avant Bio Fund II | New York, NY |
Dynamk Capital | New York, NY | ||
Avant Bio | New York, NY |
Reinhard Vogt Affiliated Funds (2)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Avant Bio Fund II | Avant Bio | Venture - General | Closed | 2023 | ||||
Dynamk Life Sciences Fund | Dynamk Capital | Venture Capital - Early Stage | Closed | 2021 |
Reinhard Vogt FAQs
-
Who is Reinhard Vogt?
Mr. Reinhard Vogt serves as a Partner at Avant Bio.
-
How much does Reinhard Vogt typically invest?
Reinhard Vogt's median deal size is
. -
What is Reinhard Vogt’s main position?
Reinhard Vogt’s primary position is Partner.
-
How many active board seats does Reinhard Vogt hold?
Reinhard Vogt holds 3 board seats including Bionter, Lucid Scientific, and Vectron Biosolutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »